Gemin X Pharmaceuticals raised $16M Series D venture round, led by Caxton Advantage Life Sciences Fund.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$24M
Top Valuation
-
Gemin X Pharmaceuticals raised $16M in a Series D round.
The round was announced on 04/20/10.
The round was led by Caxton Advantage Life Sciences Fund, Sanderling Ventures.